<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02326909</url>
  </required_header>
  <id_info>
    <org_study_id>NL42100.018.12</org_study_id>
    <nct_id>NCT02326909</nct_id>
  </id_info>
  <brief_title>Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma</brief_title>
  <official_title>a Prospective In-vivo Human Study to Assess the Diagnostic Accuracy of Optical Coherence Tomography for Diagnosis and Staging of Upper Urinary Tract Urothelial Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish in vivo sensitivity and specificity of OCT in the
      diagnosis of Upper Urinary Tract Urothelial Carcinoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Minimal invasive endoscopic treatment for Upper Urinary Tract Urothelial Carcinoma (UUT-UC)
      has been accepted as a treatment option instead of radical nephroureterectomy for patients
      with low grade, low stage disease. For this reason, information on tumour stage and grade is
      important for a clinical decision. Until now,diagnostic ureterorenoscopy combined with
      histology/cytology is the gold standard. Unfortunately, histology/cytology is often
      inconclusive.

      Optical Coherence Tomography is a new high resolution imaging technique that has potential to
      provide the urologist real time per-operative information of grade and stage of the disease.

      In this study the investigators aim to establish in vivo sensitivity and specificity of OCT
      in the diagnosis of Upper Urinary Tract Urothelial Carcinoma. Secondary objectives are
      inter-observer variability of 1300 nm OCT in the diagnosis of UUT-UC and optical properties
      of cancerous and healthy ureter and collecting system tissue in vivo in humans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of 1300nm OCT in grading and staging UUT-UC</measure>
    <time_frame>up to 10 minutes</time_frame>
    <description>Only a single OCT measurement will be done during surgery. This measurement will take a maximum of 10 minutes, including preparation of the OCT device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of 1300nm OCT in grading and staging UUT-UC</measure>
    <time_frame>up to 10 minutes</time_frame>
    <description>Only a single OCT measurement will be done during surgery. This measurement will take a maximum of 10 minutes, including preparation of the OCT device</description>
  </primary_outcome>
  <other_outcome>
    <measure>Optical properties of cancerous and healthy ureter and collecting system tissue</measure>
    <time_frame>up to 10 minutes</time_frame>
    <description>only a single OCT measurement will be done during surgery. This measurement will take a maximum of 10 minutes, including preparation of the OCT device</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Transitional Cell Carcinoma of Urinary Tract</condition>
  <arm_group>
    <arm_group_label>optical coherence tomography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A single 1300 nm OCT measurement will be performed during ureterorenoscopy in patients with upper urinary tract tumour(s)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>Single Optical Coherence Tomography measurement of upper urinary tract tumour taken during ureterorenoscopy</description>
    <arm_group_label>optical coherence tomography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>A single 1300 nm OCT measurement will be performed during ureterorenoscopy in patients with upper urinary tract tumour(s)</description>
    <arm_group_label>optical coherence tomography</arm_group_label>
    <other_name>1300 nm Optical Coherence Tomography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidate for diagnostic or therapeutic ureterorenoscopy

          -  Signed informed consent

        Exclusion Criteria:

          -  No signed informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean J. de la Rosette, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>Bus MT, Muller BG, de Bruin DM, Faber DJ, Kamphuis GM, van Leeuwen TG, de Reijke TM, de la Rosette JJ. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study. J Urol. 2013 Dec;190(6):2236-42. doi: 10.1016/j.juro.2013.08.006. Epub 2013 Aug 13.</citation>
    <PMID>23954585</PMID>
  </results_reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2014</study_first_posted>
  <last_update_submitted>December 29, 2014</last_update_submitted>
  <last_update_submitted_qc>December 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>M.T.J. Bus</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Upper Urinary Tract</keyword>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Transitional Cell Carcinoma</keyword>
  <keyword>Urothelial Cell Carcinoma</keyword>
  <keyword>Diagnostic accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Transitional Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

